Impact of Food on Pharmacokinetics and Pharmacodynamics of Asasantin ER in Healthy Subjects
NCT02273492 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2014-10-24
Summary
Comparative pharmacokinetics and pharmacodynamics of Asasantin ER at fasted and fed state
Conditions
- Healthy
Interventions
- DRUG
-
Asasantin ER
- OTHER
-
Standardized breakfast
Sponsors & Collaborators
- lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1999-08-31
- Primary Completion
- 1999-10-31
More Related Trials
-
A Study to Test How Food Influences the Amount of BI 1323495 in the Blood of Healthy Men
NCT03802331 ·Status: COMPLETED ·Phase: PHASE1
-
Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers
NCT02273531 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 135585 XX Administered as Tablet With and Without Food
NCT01286571 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood
NCT04445090 ·Status: TERMINATED ·Phase: PHASE1
-
Pharmacokinetics of Two Different Persantin® Sugar Coated Tablets in Healthy Male Volunteers
NCT02259998 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food
NCT04801693 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test How Food Influences the Amount of BI 1291583 in the Blood of Healthy Men
NCT03837964 ·Status: COMPLETED ·Phase: PHASE1
-
Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers
NCT02172209 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 3000202 Are Tolerated and How Food Influences the Amount of BI 3000202 in the Blood
NCT05945888 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study to Evaluate the Effect of Food on Pharmacokinetics of ASTX029
NCT04466514 ·Status: COMPLETED ·Phase: PHASE1
-
Food-Effect Study in Healthy Participants
NCT02233296 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Determine the Effect of Food on the Pharmacokinetics of Erdafitinib in Healthy Participants
NCT03066687 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Determine the Effect of the Timing of a Meal on the Pharmacokinetics of Entinostat
NCT02922946 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Relative Bioavailability Between Two ASP015K Tablets and the Food Effect of a New Tablet in Healthy Adult Subjects
NCT01929577 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of BIBB 515 BS and Effect of Food After Oral Administration in Healthy Subjects
NCT02266498 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetics of Single Doses of BILR 355 BS Given With Ritonavir in Healthy Male Volunteers
NCT02253953 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Men to Test How Different Doses of BI 1584862 Are Tolerated and How BI 1584862 is Taken up in the Body With or Without Food
NCT05520827 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Oral Doses and Effect of Food on the Bioavailability of BI 1060469
NCT01971502 ·Status: COMPLETED ·Phase: PHASE1
-
A Food Effect Study of JAB-21822 in Healthy Subjects
NCT05875493 ·Status: COMPLETED ·Phase: PHASE1
-
This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the Blood
NCT03210272 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Pharmacokinetics (PK) of Etrumadenant Tablet and Capsule Formulations in Healthy Adult Participants
NCT05277012 ·Status: COMPLETED ·Phase: PHASE1
-
A Bioavailability Study Comparing Modified-release Capsules and Immediate Release Capsules in Fed and Fasting Conditions
NCT01092299 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Lasmiditan in Healthy Participants
NCT03182920 ·Status: COMPLETED ·Phase: PHASE1
-
This Study Tests How Different Doses of BI 690517 Are Taken up in the Body of Healthy Men. The Study Also Looks at How Food Influences the Amount of BI 690517 in the Blood
NCT03100916 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Bioavailability of Different Formulations of AZD5718 and the Food Effect on the Selected Formulation of AZD5718 in Healthy Volunteers
NCT03420092 ·Status: COMPLETED ·Phase: PHASE1